Интерстициальное поражение легких и его диагностика при системной склеродермии (прогрессирующем системном склерозе)

1. <div><p>Гусева Н. Г. Системная склеродермия и псевдоскле- родермические синдромы. М.Медицина, 1993.</p><p>Гусева Н.Г. Проблемы диагностики и лечения системной склеродермии. Рус. мед. жури., 1998, 6, 8(68),486-482.</p><p>Георгиади С.Г., Котляров П.М. Компьютерно — томографические признаки диффузных заболеваний легких. Вестник, РНЦРР М3 РФ, 2004, 4.</p><p>Коган Е.А., Коренев Б.М., Попова Е.Н. и др. Интерстициальные болезни легких. М.,Литтера, 2007,186-191.</p><p>Насонова В.А., Астапенко М.Г. Клиническая ревматология. М., Медицина, 1989,175-193.</p><p>Спасская П.А., Бартусевичене А.С. Клиническая рентгенодиагностика коллагенозов. Вильнюс, Мокслас, 1988, 66-104.</p><p>Тюрин И.Е. Компьютерная томография органов грудной полости. ЭЛБИ-СПб, 2003, 324-330.</p><p>Чучалин А. Г. Клинические рекомендации. Пульмонология. М., ГЭОТАР-Медиа, 2007,1-37.</p><p>Altman R.D., Medsger Т.А. Jr, Bloch D.A. et al. Predictors of survival in systemic sclerosis (scleroderma). Arthr. Rheum., 1991,34(4),403-413.</p><p>Andrew G., Nicholson A.G., Colby TV. et at. The prognostic significance of the histologic pattern of interstizial pneumonia in patients presenting with the clinical entity of cryptogenetic fibrosing alveolitis. Am. J. Respir. Crit. Care Med., 2000,162,2213-2217</p><p>Battle R. W., Davitt M.A., Cooper S.M. et al. Prevalence of pulmonary’ hypertension in limited and diffuse scleroderma. Chest, 1996,110(6),1515-1519.</p><p>Berman J.S. Lymphocytes in the lung: should we continue to exalt only BALT?Am. J. Respir. Cell Mol. Biol., 1990,3(2), 101-102.</p><p>Bouros D. Wells A.U., Nicholson A.G. et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med., 2002,15,165(12), 1581-1586.</p><p>Bryan C., Knight C., Black C.M. et al. Prediction of five-year survival following presentation with scleroderта: development of a simple model using three disease factors at first visit. Arthr. Rheum., 1999,42(12),2660- 2665.</p><p>Bulpitt K.J., Clements P.J., Lachenbruch P.A. et al. Early undifferentiated connective tissue disease:</p><p>Outcome and prognostic indicators in early scleroderma (systemic sclerosis).Ann. Intern. Med., 1993,15,118(8),602-609.</p><p>Catterall М., Rowell N.R. Respiratory function in progressive systemic sclerosis. Thorax, 1963,18,10-15.</p><p>Clements P., Goldin J., Kleerup E. et al. Regional differences in bronchoalveolar lavage amd thoracic high-resolution computed tomography results in dys- pno patients with systemic sclerosis. Arthr. Rheum., 2004,50,1909-1917</p><p>Co Ip C.R., RikerJ., Williams М.И. Jr. Serial changes in scleroderma and idiopathic interstitial lung disease. Arch. Intern. Med.,1973,132(4),506-515.</p><p>DAngelo W.A., Fries J.F., Masi A.T. et al. Pathologic observations in systemic sclerosis (scleroderma):a study of fifty-eight autopsy cases and fifty-eight matched controls. Am. J. Med., 1969,46,428-440</p><p>Desai S.R., Veeraraghavan S., Hansel I D.M. et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology,2004,232(2),560-567.</p><p>DeSantis М., BoselloS., La TorreG. etal. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis. Respir. Res., 2005,17,6,96.</p><p>FerriC., Valentini G., Cozzi F. et al. Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore)., 2002,81(2), 139153.</p><p>Flaherty K.R., TowesG.B., Travis W.D. etal. Clinical significance of histologic classification of idiopathic interstizial pneumonia. Eur. Respir. J., 2002,19,275283.</p><p>Greidinger E.L., Flaherty К.Т., White В. et al. African- American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest, 1998,114(3),801-807.</p><p>Гриппы M.A. Патофизиология легких. М.,Бином, 2005,130-141.</p><p>Hesse/strand R., Scheja A., Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann. Rheum. Dis., 1998,57,682-686.</p><p>Jacobsen S., Halberg P., Ullman S. etal. A longitudinal study ofpulmonary Junction in Danish patients with systemic sclerosis. Clin. Rheumatol., 1997,16(4),384-390.</p><p>KaloudiO., Miniati 1., Atari S. Interstitial lung disease in systemic sclerosis. Intern. Emerg. Med., 2007, 2(4), 250-255.</p><p>Kim D.S., Yoo B., Lee J.S. et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vase. Diffuse Lung Dis.,2002,19(2), 121-127.</p><p>Lee P., Langevitz P., Alderdice C.A. et al. Mortality in systemic sclerosis (scleroderma). Q. J. Med., 1992,82(298), 139-148.</p><p>Maricq H.R., Weinrich M.C., Keil J.E. et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthr. Rheum., 1989,32(8), 998-1006.</p><p>McNearney T.A., Reveille J.D., Fischbach M. et al. Pulmonary involvement in systemic sclerosis: associations with genetic,serologic, sociodemographic, and behavioral factors. Arthr. Rheum., 2007. 15.57(2), 318-326.</p><p>Pignone A., Matucci-Cerinic М., Lombardi A. et al. High resolution computed tomography in systemic sclerosis. Real diagnostic utilities in the assessment of pulmonary involvement and comparison with other modalities of lung investigation. Clin. Rheumatol., 1992,11(4), 465-472.</p><p>Remy—Jardin М., Remy J., Wallaert B. Pulmonary involvement in progressive systemic sclerosis '.sequential evaluation with CT, pulmonary tests and broncho- alveolar lavage. Radiology, 1993, 188,499-506.</p><p>Schurawitzki H., Stiglbauer R., Graninger W. et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology, 1990,176(3),755-759.</p><p>Silman A.J. Epidemiology of scleroderma. Curr. Opin. Rheumatol., 1991,3(6), 967-972.</p><p>Silver R.М., Miller K.S. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am. J. Med. 1990, 88, 470-476.</p><p>Steen V.D., Conte C., Owens G.R. Severe restrictive lung disease in systemic sclerosis. Arthr. Rheum., 1994,37(9), 1283-1289.</p><p>Steen V.D., Medsger T.A. Jr. Long-term outcomes of scleroderma renal crisis. Ann. Intern. Med., 2000,17,133(8),600-603.</p><p>Steen V.D., Medsger T.A. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthr. Rheum., 2000,43,2437-2444.</p><p>Steen V.D., Medsger T.A.Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneus involvement. Arthtr. Rheum. 2003, 48,516-522.</p><p>Steen V.D. The lung in systemic sclerosis. J. Clin. Rheumatol.,2005,11(1),40-46.</p><p>Steen V.D., Medsger T.A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann. Rheum. Dis.,2007,66(7),940-944.</p><p>Travis W.D., Matsui K., Moss J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: sur’ival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol.,2000,24(1), 19-33.</p><p>Warrick J.H., Bit a I la М., Schabel S. I. High resolution computed tomography in early scleroderma lung disease. J. Rheumatol., 1991,18(10), 1520-1528.</p><p>Weaver A. L., Divertie M.B., Titus J.L. Pulmonary scleroderma. Dis. Chest, 1968,54(6),490-498.</p><p>Wells A. U., Hansell D. М., Rubens М. B. et al. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am. J. Respir. Crit. Care Med., 1994,150(2),462- 468.</p><p>Wells A. U., Hansell D. M., Rubens М. B. et at. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. Arthr. Rheum., 1997,40(7), 1229-1236.</p><p>White B., Moore W. C., Wigley F. M. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann. Intern. Med., 2000,132,947-954.</p><p>Witt C., Borgess A.C., John M. et al. Pulmonary involvement in difuse cutaneous systemic sclerosis.bronchoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis Ann. Rheum. Dis., 1999,58,635-640.</p></div><br />